{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:18:01Z","timestamp":1783163881718,"version":"3.54.6"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-025-11417-x","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T07:46:22Z","timestamp":1764747982000},"page":"4701-4717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Study on the structure\u2013activity relationships of natural \u03b3-pyranone products and their derivatives with anti-AD activities focusing on metal chelation"],"prefix":"10.1007","volume":"30","author":[{"given":"Junyi","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8491-0471","authenticated-orcid":false,"given":"Rui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0827-655X","authenticated-orcid":false,"given":"Aihong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-5819","authenticated-orcid":false,"given":"Xiaodi","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"1","key":"11417_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010107","volume":"24","author":"AA Rostagno","year":"2022","unstructured":"Rostagno AA (2022) Pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci 24(1):107. https:\/\/doi.org\/10.3390\/ijms24010107","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11417_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","volume":"10","author":"W Xiao","year":"2025","unstructured":"Xiao W, Jiang W, Chen Z et al (2025) Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. Signal Transduct Target Ther 10(1):74. https:\/\/doi.org\/10.1038\/s41392-024-02107-5","journal-title":"Signal Transduct Target Ther"},{"key":"11417_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","volume":"167","author":"JA Soria Lopez","year":"2019","unstructured":"Soria Lopez JA, Gonz\u00e1lez HM, L\u00e9ger GC (2019) Alzheimer\u2019s disease. Handb Clin Neurol 167:231\u2013255. https:\/\/doi.org\/10.1016\/B978-0-12-804766-8.00013-3","journal-title":"Handb Clin Neurol"},{"key":"11417_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102595","volume":"103","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Chen J, Li Y et al (2025) Disease-modifying therapies for Alzheimer\u2019s disease: clinical trial progress and opportunity. Ageing Res Rev 103:102595. https:\/\/doi.org\/10.1016\/j.arr.2024.102595","journal-title":"Ageing Res Rev"},{"key":"11417_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173554","volume":"887","author":"M Vaz","year":"2020","unstructured":"Vaz M, Silvestre S (2020) Alzheimer\u2019s disease: recent treatment strategies. Eur J Pharmacol 887:173554. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173554","journal-title":"Eur J Pharmacol"},{"key":"11417_CR6","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.934077","volume":"27","author":"DV Parums","year":"2021","unstructured":"Parums DV (2021) Editorial: targets for disease-modifying therapies in Alzheimer\u2019s disease, including amyloid \u03b2 and tau protein. Med Sci Monit 27:e934077. https:\/\/doi.org\/10.12659\/MSM.934077","journal-title":"Med Sci Monit"},{"issue":"2","key":"11417_CR7","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE et al (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7(2):e105\u2013e125. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8","journal-title":"Lancet Public Health"},{"issue":"1","key":"11417_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41380-024-02709-z","volume":"30","author":"TR Hunter","year":"2025","unstructured":"Hunter TR, Santos LE, Tovar-Moll F et al (2025) Alzheimer\u2019s disease biomarkers and their current use in clinical research and practice. Mol Psychiatry 30(1):272\u2013284. https:\/\/doi.org\/10.1038\/s41380-024-02709-z","journal-title":"Mol Psychiatry"},{"key":"11417_CR9","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/febs.14004","volume":"284","author":"J Hardy","year":"2017","unstructured":"Hardy J (2017) The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the \u2033amyloid cascade hypothesis\u201d. FEBS J 284:1040\u20131044. https:\/\/doi.org\/10.1111\/febs.14004","journal-title":"FEBS J"},{"issue":"9","key":"11417_CR10","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.jmb.2019.01.018","volume":"431","author":"TJ Huat","year":"2019","unstructured":"Huat TJ, Camats-Perna J, Newcombe EA et al (2019) Metal toxicity links to Alzheimer\u2019s disease and neuroinflammation. J Mol Biol 431(9):1843\u20131868. https:\/\/doi.org\/10.1016\/j.jmb.2019.01.018","journal-title":"J Mol Biol"},{"key":"11417_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2174\/0118715273355336250226055826","volume":"24","author":"N Puranik","year":"2025","unstructured":"Puranik N, Song M (2025) Oxidative stress and the role of immune cells in Alzheimer\u2019s disease: therapeutic implications and future perspectives. CNS Neurol Disord Drug Targets 24:685\u2013700. https:\/\/doi.org\/10.2174\/0118715273355336250226055826","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"11417_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neuroscience.2020.04.019","volume":"438","author":"H Chidambaram","year":"2020","unstructured":"Chidambaram H, Chinnathambi S (2020) G-protein coupled receptors and tau-different roles in Alzheimer\u2019s disease. Neuroscience 438:198\u2013214. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.04.019","journal-title":"Neuroscience"},{"key":"11417_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/s1474-4422(03)00502-7","volume":"2","author":"E Scarpini","year":"2003","unstructured":"Scarpini E, Schelterns P, Feldman H (2003) Treatment of Alzheimer\u2019s disease: current status and new perspectives. Lancet Neurol 2:539\u2013547. https:\/\/doi.org\/10.1016\/s1474-4422(03)00502-7","journal-title":"Lancet Neurol"},{"issue":"10","key":"11417_CR14","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00228-022-03363-6","volume":"78","author":"R Majidazar","year":"2022","unstructured":"Majidazar R, Rezazadeh-Gavgani E, Sadigh-Eteghad S et al (2022) Pharmacotherapy of Alzheimer\u2019s disease: an overview of systematic reviews. Eur J Clin Pharmacol 78(10):1567\u20131587. https:\/\/doi.org\/10.1007\/s00228-022-03363-6","journal-title":"Eur J Clin Pharmacol"},{"issue":"20","key":"11417_CR15","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.2174\/1389557521666210304111754","volume":"21","author":"P Teli","year":"2021","unstructured":"Teli P, Sahiba N, Soni J et al (2021) Exploration of potent multi-target-directed-ligands as anti-Alzheimer\u2019s disease agents: a moiety based review. Mini Rev Med Chem 21(20):3219\u20133248. https:\/\/doi.org\/10.2174\/1389557521666210304111754","journal-title":"Mini Rev Med Chem"},{"issue":"10","key":"11417_CR16","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2174\/0929867328666210512005508","volume":"29","author":"B Kumar","year":"2022","unstructured":"Kumar B, Thakur A, Dwivedi AR et al (2022) Multi-target-directed ligands as an effective strategy for the treatment of Alzheimer\u2019s disease. Curr Med Chem 29(10):1757\u20131803. https:\/\/doi.org\/10.2174\/0929867328666210512005508","journal-title":"Curr Med Chem"},{"key":"11417_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202500053","volume":"28","author":"NV Mehta","year":"2025","unstructured":"Mehta NV, Kapadia A, Khambete M et al (2025) The evolution of AChE inhibitors in Alzheimer\u2019s disease: from single-target to multi-target ligands. ChemBioChem 28:e2500053. https:\/\/doi.org\/10.1002\/cbic.202500053","journal-title":"ChemBioChem"},{"issue":"4","key":"11417_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.70131","volume":"13","author":"MS Hossain","year":"2025","unstructured":"Hossain MS, Hussain MH et al (2025) Multi-target drug design in Alzheimer\u2019s diseasetreatment: emerging technologies, advantages, challenges, and limitations. Pharmacol Res Perspect 13(4):e70131. https:\/\/doi.org\/10.1002\/prp2.70131","journal-title":"Pharmacol Res Perspect"},{"key":"11417_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110173","volume":"367","author":"K Jomova","year":"2022","unstructured":"Jomova K, Makova M, Alomar SY et al (2022) Essential metals in health and disease. Chem Biol Interact 367:110173. https:\/\/doi.org\/10.1016\/j.cbi.2022.110173","journal-title":"Chem Biol Interact"},{"key":"11417_CR20","doi-asserted-by":"publisher","first-page":"12442","DOI":"10.3390\/ijms222212442","volume":"22","author":"Y Peng","year":"2021","unstructured":"Peng Y, Chang X, Lang M (2021) Iron homeostasis disorder and Alzheimer\u2019s disease. Int J Mol Sci 22:12442. https:\/\/doi.org\/10.3390\/ijms222212442","journal-title":"Int J Mol Sci"},{"key":"11417_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.903099","volume":"13","author":"F Islam","year":"2022","unstructured":"Islam F, Shohag S, Akhter S et al (2022) Exposure of metal toxicity in Alzheimer\u2019s disease: an extensive review. Front Pharmacol 13:903099. https:\/\/doi.org\/10.3389\/fphar.2022.903099","journal-title":"Front Pharmacol"},{"key":"11417_CR22","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1042\/BST0361282","volume":"36","author":"JT Rogers","year":"2008","unstructured":"Rogers JT, Bush AI, Cho HH et al (2008) Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer\u2019s disease. Biochem Soc Trans 36:1282\u20131287. https:\/\/doi.org\/10.1042\/BST0361282","journal-title":"Biochem Soc Trans"},{"key":"11417_CR23","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3233\/JAD-230801","volume":"99","author":"RA Syed","year":"2024","unstructured":"Syed RA, Hayat M, Qaiser H et al (2024) Aging-related protein alterations in the brain. J Alzheimers Dis 99:S5\u2013S22. https:\/\/doi.org\/10.3233\/JAD-230801","journal-title":"J Alzheimers Dis"},{"key":"11417_CR24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s10072-014-1668-x","volume":"35","author":"Y Yuan","year":"2014","unstructured":"Yuan Y, Niu F, Liu Y et al (2014) Zinc and its effects on oxidative stress in Alzheimer\u2019s disease. Neurol Sci 35:923\u2013928. https:\/\/doi.org\/10.1007\/s10072-014-1668-x","journal-title":"Neurol Sci"},{"key":"11417_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112257","volume":"198","author":"YP Singh","year":"2020","unstructured":"Singh YP, Tej GNVC, Pandey A et al (2020) Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer\u2019s disease. Eur J Med Chem 198:112257. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112257","journal-title":"Eur J Med Chem"},{"key":"11417_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116385","volume":"46","author":"YP Singh","year":"2021","unstructured":"Singh YP, Shankar G, Jahan S et al (2021) Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem 46:116385. https:\/\/doi.org\/10.1016\/j.bmc.2021.116385","journal-title":"Bioorg Med Chem"},{"key":"11417_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108666","volume":"163","author":"AE Shaaban","year":"2025","unstructured":"Shaaban AE, Ali AR, Ayyad SN et al (2025) Unveiling the potential of novel natural product-based MTDLs that integrate cinnamamide scaffold as multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Chem 163:108666. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108666","journal-title":"Bioorg Chem"},{"key":"11417_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108731","volume":"264","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Nan F, Zhang Q et al (2024) Natural products that alleviate depression: the putative role of autophagy. Pharmacol Ther 264:108731. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108731","journal-title":"Pharmacol Ther"},{"key":"11417_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s12032-025-02894-z","volume":"42","author":"T Naveed","year":"2025","unstructured":"Naveed T, Ali S, Summer M (2025) Bioactive compounds in Raphanus sativus: mechanisms of apoptosis, anti-angiogenesis, cell cycle arrest and beyond in cancer prevention and treatment. Med Oncol 42:328. https:\/\/doi.org\/10.1007\/s12032-025-02894-z","journal-title":"Med Oncol"},{"issue":"1","key":"11417_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2011.09.010","volume":"52","author":"RJ Williams","year":"2012","unstructured":"Williams RJ, Spencer JPE (2012) Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic Biol Med 52(1):35\u201345. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.09.010","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"11417_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47080635","volume":"47","author":"J Szala-Rycaj","year":"2025","unstructured":"Szala-Rycaj J, Zagaja M, Szewczyk A et al (2025) Neuroprotective potential of phytocompounds in the treatment of dementia: the state of knowledge from the scopolamine-induced animal model of Alzheimer\u2019s disease. Curr Issues Mol Biol 47(8):635. https:\/\/doi.org\/10.3390\/cimb47080635","journal-title":"Curr Issues Mol Biol"},{"issue":"5","key":"11417_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/biof.70047","volume":"51","author":"MY Zamanian","year":"2025","unstructured":"Zamanian MY, Khachatryan LG, Heidari M et al (2025) The therapeutic potential of flavonols in Alzheimer\u2019s disease: inhibiting amyloid-\u03b2, oxidative stress, and neuroinflammation. BioFactors 51(5):e70047. https:\/\/doi.org\/10.1002\/biof.70047","journal-title":"BioFactors"},{"issue":"4","key":"11417_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14529","volume":"103","author":"A Yang","year":"2024","unstructured":"Yang A, Yi X, Zhang H et al (2024) Diosmetin derivatives as multifunctional anti\u2010AD ligands: design, synthesis, and biological evaluation. Chem Biol Drug Des 103(4):e14529. https:\/\/doi.org\/10.1111\/cbdd.14529","journal-title":"Chem Biol Drug Des"},{"key":"11417_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.842208","volume":"10","author":"X Hu","year":"2022","unstructured":"Hu X, Liu C, Wang K et al (2022) Multifunctional anti-Alzheimer\u2019s disease effects of natural xanthone derivatives: a primary structure-activity evaluation. Front Chem 10:842208. https:\/\/doi.org\/10.3389\/fchem.2022.842208","journal-title":"Front Chem"},{"key":"11417_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2022.112086","volume":"239","author":"C Liu","year":"2023","unstructured":"Liu C, Wu J, Hu C et al (2023) Synthesis, single crystal characterization and anti-AD activities of a novel complex of Cu(II) with in situ formed protonated chrysin derivative ligand. J Inorg Biochem 239:112086. https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.112086","journal-title":"J Inorg Biochem"},{"issue":"18","key":"11417_CR36","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.3390\/molecules26185575","volume":"26","author":"Q Huang","year":"2021","unstructured":"Huang Q, Wang Y, Wu H et al (2021) Xanthone glucosides: isolation, bioactivity and synthesis. Molecules 26(18):5575. https:\/\/doi.org\/10.3390\/molecules26185575","journal-title":"Molecules"},{"issue":"2","key":"11417_CR37","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","volume":"119","author":"MG Savelieff","year":"2019","unstructured":"Savelieff MG, Nam G, Kang J et al (2019) Development of multifunctional molecules as potential therapeutic candidates for Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis in the last decade. Chem Rev 119(2):1221\u20131322. https:\/\/doi.org\/10.1021\/acs.chemrev.8b00138","journal-title":"Chem Rev"},{"issue":"9\u201310","key":"11417_CR38","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/s0278-6915(99)00079-4","volume":"37","author":"PC Hollman","year":"1999","unstructured":"Hollman PC, Katan MB (1999) Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol 37(9\u201310):937\u2013942. https:\/\/doi.org\/10.1016\/s0278-6915(99)00079-4","journal-title":"Food Chem Toxicol"},{"key":"11417_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/10715769900301351","volume":"31","author":"PCH Hollman","year":"1999","unstructured":"Hollman PCH, Katan MB (1999) Health effects and bioavailability of dietary flavonols. Free Radic Res 31:75\u201380. https:\/\/doi.org\/10.1080\/10715769900301351","journal-title":"Free Radic Res"},{"issue":"23","key":"11417_CR40","doi-asserted-by":"publisher","first-page":"14835","DOI":"10.3390\/ijms232314835","volume":"23","author":"A Calderaro","year":"2022","unstructured":"Calderaro A, Patan\u00e8 GT, Tellone E et al (2022) The neuroprotective potentiality of flavonoids on Alzheimer\u2019s disease. Int J Mol Sci 23(23):14835. https:\/\/doi.org\/10.3390\/ijms232314835","journal-title":"Int J Mol Sci"},{"key":"11417_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102772","volume":"109","author":"D Das","year":"2025","unstructured":"Das D, Das A, Bhattacharya K et al (2025) Xanthones as neuroprotective agents: a comprehensive review of their role in the prevention and treatment of neurodegenerative diseases. Ageing Res Rev 109:102772. https:\/\/doi.org\/10.1016\/j.arr.2025.102772","journal-title":"Ageing Res Rev"},{"key":"11417_CR42","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1007\/s11064-023-04005-8","volume":"48","author":"LW Pang","year":"2023","unstructured":"Pang LW, Hamzah S, Tan SLJ et al (2023) The effects and mechanisms of xanthones in Alzheimer\u2019s disease: a systematic review. Neurochem Res 48:3485\u20133511. https:\/\/doi.org\/10.1007\/s11064-023-04005-8","journal-title":"Neurochem Res"},{"issue":"5","key":"11417_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.phrs.2004.11.002","volume":"51","author":"G Pardo Andreu","year":"2005","unstructured":"Pardo Andreu G, Delgado R, Velho J et al (2005) Mangifera indica L. extract (Vimang) inhibits Fe2+-citrate-induced lipoperoxidation in isolated rat liver mitochondria. Pharmacol Res 51(5):427\u2013435. https:\/\/doi.org\/10.1016\/j.phrs.2004.11.002","journal-title":"Pharmacol Res"},{"issue":"1\u20132","key":"11417_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejphar.2005.03.007","volume":"513","author":"GP Andreu","year":"2005","unstructured":"Andreu GP, Delgado R, Velho JA et al (2005) Iron complexing activity of mangiferin, a naturally occurring glucosylxanthone, inhibits mitochondrial lipid peroxidation induced by Fe2+-citrate. Eur J Pharmacol 513(1\u20132):47\u201355. https:\/\/doi.org\/10.1016\/j.ejphar.2005.03.007","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"11417_CR45","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/ptr.6864","volume":"35","author":"K Naraki","year":"2021","unstructured":"Naraki K, Rezaee R, Mashayekhi-Sardoo H et al (2021) Mangiferin offers protection against deleterious effects of pharmaceuticals, heavy metals, and environmental chemicals. Phytother Res 35(2):810\u2013822. https:\/\/doi.org\/10.1002\/ptr.6864","journal-title":"Phytother Res"},{"issue":"4","key":"11417_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1055\/a-0667-8530","volume":"69","author":"A Estuningtyas","year":"2019","unstructured":"Estuningtyas A, Setiabudy R, Wahidiyat P et al (2019) The role of mangiferin in the prevention of experimentally induced iron overload in an animal model. Drug Res 69(4):234\u2013240. https:\/\/doi.org\/10.1055\/a-0667-8530","journal-title":"Drug Res"},{"key":"11417_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2856063","volume":"2018","author":"E Alberdi","year":"2018","unstructured":"Alberdi E, S\u00e1nchez-G\u00f3mez MV, Ruiz A et al (2018) Mangiferin and morin attenuate oxidative stress, mitochondrial dysfunction, and neurocytotoxicity, induced by amyloid beta oligomers. Oxid Med Cell Longev 2018:2856063. https:\/\/doi.org\/10.1155\/2018\/2856063","journal-title":"Oxid Med Cell Longev"},{"key":"11417_CR48","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1007\/s11064-016-1896-y","volume":"41","author":"SN Wang","year":"2016","unstructured":"Wang SN, Li Q, Jing MH et al (2016) Natural xanthones from Garcinia mangostana with multifunctional activities for the therapy of Alzheimer\u2019s disease. Neurochem Res 41:1806\u20131817. https:\/\/doi.org\/10.1007\/s11064-016-1896-y","journal-title":"Neurochem Res"},{"issue":"11","key":"11417_CR49","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.phymed.2014.06.017","volume":"21","author":"KY Khaw","year":"2014","unstructured":"Khaw KY, Choi SB, Tan SC et al (2014) Prenylated xanthones from mangosteen as promising cholinesterase inhibitors and their molecular docking studies. Phytomedicine 21(11):1303\u20131309. https:\/\/doi.org\/10.1016\/j.phymed.2014.06.017","journal-title":"Phytomedicine"},{"issue":"6","key":"11417_CR50","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/cns.12699","volume":"23","author":"LX Zhao","year":"2017","unstructured":"Zhao LX, Wang Y, Liu T et al (2017) \u03b1-Mangostin decreases \u03b2-amyloid peptides production via modulation of amyloidogenic pathway. CNS Neurosci Ther 23(6):526\u2013534. https:\/\/doi.org\/10.1111\/cns.12699","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"11417_CR51","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00011-019-01232-0","volume":"68","author":"Y Ge","year":"2019","unstructured":"Ge Y, Xu X, Liang Q et al (2019) \u03b1-Mangostin suppresses NLRP3 inflammasome activation via promoting autophagy in LPS-stimulated murine macrophages and protects against CLP-induced sepsis in mice. Inflamm Res 68(6):471\u2013479. https:\/\/doi.org\/10.1007\/s00011-019-01232-0","journal-title":"Inflamm Res"},{"key":"11417_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.149506","volume":"1852","author":"MC Chiang","year":"2015","unstructured":"Chiang MC, Nicol CJB, Yang YP et al (2015) The \u03b1-MG exhibits neuroprotective potential by reducing amyloid beta peptide-induced inflammation, oxidative stress, and tau aggregation in human neural stem cells. Brain Res 1852:149506. https:\/\/doi.org\/10.1016\/j.brainres.2025.149506","journal-title":"Brain Res"},{"issue":"5","key":"11417_CR53","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10571-015-0264-9","volume":"36","author":"Z Hu","year":"2016","unstructured":"Hu Z, Wang W, Ling J et al (2016) \u03b1-Mangostin inhibits a-synuclein-induced microglial neuroinflammation and neurotoxicity. Cell Mol Neurobiol 36(5):811\u2013820. https:\/\/doi.org\/10.1007\/s10571-015-0264-9","journal-title":"Cell Mol Neurobiol"},{"key":"11417_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173950","volume":"897","author":"A Yang","year":"2021","unstructured":"Yang A, Liu C, Wu J et al (2021) A review on \u03b1-mangostin as a potential multi-target-directed ligand for Alzheimer\u2019s disease. Eur J Pharmacol 897:173950. https:\/\/doi.org\/10.1016\/j.ejphar.2021.173950","journal-title":"Eur J Pharmacol"},{"key":"11417_CR55","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1016\/j.bmcl.2005.08.099","volume":"15","author":"BW Lee","year":"2006","unstructured":"Lee BW, Lee JH, Lee ST et al (2006) Antioxidant and cytotoxic activities of xanthones from Cudrania tricuspidata. Bioorg Med Chem Lett 15:5548\u20135552. https:\/\/doi.org\/10.1016\/j.bmcl.2005.08.099","journal-title":"Bioorg Med Chem Lett"},{"issue":"13","key":"11417_CR56","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1080\/14786419.2011.561494","volume":"26","author":"C Uvarani","year":"2012","unstructured":"Uvarani C, Chandraprakash K, Sankaran M et al (2012) Antioxidant and structure-activity relationships of five tetraoxygenated xanthones from Swertia minor (Griscb.) Knobl. Nat Prod Res 26(13):1265\u20131270. https:\/\/doi.org\/10.1080\/14786419.2011.561494","journal-title":"Nat Prod Res"},{"issue":"10","key":"11417_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202000442","volume":"17","author":"A Yang","year":"2020","unstructured":"Yang A, Yu Q, Ju H et al (2020) Design, synthesis and biological evaluation of xanthone derivatives for possible treatment of Alzheimer\u2019s disease based on multi-target strategy. Chem Biodivers 17(10):e2000442. https:\/\/doi.org\/10.1002\/cbdv.202000442","journal-title":"Chem Biodivers"},{"issue":"4","key":"11417_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.126927","volume":"30","author":"X Kou","year":"2020","unstructured":"Kou X, Song L, Wang Y et al (2020) Design, synthesis and anti-Alzheimer\u2019s disease activity study of xanthone derivatives based on multi-target strategy. Bioorg Med Chem Lett 30(4):126927. https:\/\/doi.org\/10.1016\/j.bmcl.2019.126927","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"11417_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400671","volume":"358","author":"Q Chen","year":"2025","unstructured":"Chen Q, Li X, Xiao W et al (2025) Design, synthesis, biological evaluation, and X-ray single crystal structure of novel computer-aided-drug-designbased \u03b1-mangostin derivatives: multifunctional ligands against Alzheimer\u2019s disease. Arch Pharm (Weinheim) 358(3):e2400671. https:\/\/doi.org\/10.1002\/ardp.202400671","journal-title":"Arch Pharm (Weinheim)"},{"key":"11417_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113154","volume":"213","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Guo J, Cheng M et al (2021) Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 213:113154. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113154","journal-title":"Eur J Med Chem"},{"issue":"6","key":"11417_CR61","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.bmc.2017.02.027","volume":"25","author":"L Luo","year":"2017","unstructured":"Luo L, Li Y, Qiang X et al (2017) Multifunctional thioxanthone derivatives with acetylcholinesterase, monoamine oxidases and \u03b2 -amyloid aggregation inhibitory activities as potential agents against Alzheimer\u2019s disease. Bioorg Med Chem 25(6):1997\u20132009. https:\/\/doi.org\/10.1016\/j.bmc.2017.02.027","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"11417_CR62","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2174\/1570159X23666241211095018","volume":"23","author":"N Zhang","year":"2025","unstructured":"Zhang N, Nao J, Dong X (2025) Efficacy and safety of natural apigenin treatment for Alzheimer\u2019s disease: focus on in vivo research advancements. Curr Neuropharmacol 23(6):728\u2013754. https:\/\/doi.org\/10.2174\/1570159X23666241211095018","journal-title":"Curr Neuropharmacol"},{"key":"11417_CR63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainres.2012.11.019","volume":"1492","author":"L Zhao","year":"2013","unstructured":"Zhao L, Wang J, Wang Y et al (2013) Apigenin attenuates copper-mediated \u03b2-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signal inactivation in an AD cell model. Brain Res 1492:33\u201345. https:\/\/doi.org\/10.1016\/j.brainres.2012.11.019","journal-title":"Brain Res"},{"issue":"3","key":"11417_CR64","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4062\/biomolther.2022.136","volume":"31","author":"YJ Chiu","year":"2023","unstructured":"Chiu YJ, Teng YS, Chen CM et al (2023) A neuroprotective action of Quercetin and Apigenin through inhibiting aggregation of A\u03b2 and activation of TRKB signaling in a cellular experiment. Biomol Ther (Seoul) 31(3):285\u2013297. https:\/\/doi.org\/10.4062\/biomolther.2022.136","journal-title":"Biomol Ther (Seoul)"},{"issue":"4\u20135","key":"11417_CR65","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.neuint.2007.10.005","volume":"52","author":"SK Ha","year":"2008","unstructured":"Ha SK, Lee P, Park JA et al (2008) Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem Int 52(4\u20135):878\u2013886. https:\/\/doi.org\/10.1016\/j.neuint.2007.10.005","journal-title":"Neurochem Int"},{"key":"11417_CR66","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JAD-2010-101593","volume":"24","author":"R Liu","year":"2011","unstructured":"Liu R, Zhang T, Yang H et al (2011) The flavonoid apigenin protects brain neurovascular coupling against amyloid-\u03b225-35-induced toxicity in mice. J Alzheimers Dis 24:85\u2013100. https:\/\/doi.org\/10.3233\/JAD-2010-101593","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"11417_CR67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/138955709787001712","volume":"9","author":"M Lopez-Lazaro","year":"2009","unstructured":"Lopez-Lazaro M (2009) Distribution and biological activities of the flavonoid luteolin. Mini-Rev Med Chem 9(1):31\u201359. https:\/\/doi.org\/10.2174\/138955709787001712","journal-title":"Mini-Rev Med Chem"},{"issue":"14","key":"11417_CR68","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1055\/s-0028-1088314","volume":"74","author":"G Seelinger","year":"2008","unstructured":"Seelinger G, Merfort I, Schempp CM (2008) Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med 74(14):1667\u20131677. https:\/\/doi.org\/10.1055\/s-0028-1088314","journal-title":"Planta Med"},{"issue":"9","key":"11417_CR69","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2174\/1567205011666141001113619","volume":"11","author":"D Wei","year":"2014","unstructured":"Wei D, Tang J, Bai W et al (2014) Ameliorative effects of baicalein on an amyloid-\u03b2 induced Alzheimer\u2019s disease rat model: a proteomics study. Curr Alzheimer Res 11(9):869\u2013881. https:\/\/doi.org\/10.2174\/1567205011666141001113619","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"11417_CR70","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/00207454.2024.2332963","volume":"135","author":"J Zhao","year":"2025","unstructured":"Zhao J, Lu F, Yu H et al (2025) Proteomic analysis of baicalin intervention on protein expression and modification in the hippocampus of Alzheimer\u2019s disease model rat. Int J Neurosci 135(7):797\u2013806. https:\/\/doi.org\/10.1080\/00207454.2024.2332963","journal-title":"Int J Neurosci"},{"issue":"8","key":"11417_CR71","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1039\/d3fo05566c","volume":"15","author":"Q Dong","year":"2024","unstructured":"Dong Q, Cui Z, Wu X et al (2024) Natural flavonoid hesperetin blocks amyloid \u03b2-protein fibrillogenesis, depolymerizes preformed fibrils and alleviates cytotoxicity caused by amyloids. Food Funct 15(8):4233\u20134245. https:\/\/doi.org\/10.1039\/d3fo05566c","journal-title":"Food Funct"},{"issue":"12","key":"11417_CR72","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.4103\/1673-5374.373680","volume":"18","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Yan Y (2023) The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer\u2019s disease: a narrative review. Neural Regen Res 18(12):2582\u20132591. https:\/\/doi.org\/10.4103\/1673-5374.373680","journal-title":"Neural Regen Res"},{"issue":"1","key":"11417_CR73","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s42003-024-06615-6","volume":"7","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Guo X, Li S et al (2024) Naringenin ameliorates amyloid-\u03b2 pathology and neuroinflammation in Alzheimer\u2019s disease. Commun Biol 7(1):912. https:\/\/doi.org\/10.1038\/s42003-024-06615-6","journal-title":"Commun Biol"},{"issue":"5","key":"11417_CR74","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","volume":"79","author":"C Manach","year":"2004","unstructured":"Manach C, Scalbert A, Morand C et al (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79(5):727\u2013747. https:\/\/doi.org\/10.1093\/ajcn\/79.5.727","journal-title":"Am J Clin Nutr"},{"key":"11417_CR75","doi-asserted-by":"publisher","first-page":"ES60","DOI":"10.1017\/S0007114508965776","volume":"99","author":"JPE Spencer","year":"2008","unstructured":"Spencer JPE (2008) Flavonoids: modulators of brain function? Br J Nutr 99:ES60\u2013ES77. https:\/\/doi.org\/10.1017\/S0007114508965776","journal-title":"Br J Nutr"},{"issue":"7","key":"11417_CR76","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1532-5415.1996.tb03749.x","volume":"44","author":"SJ Birge","year":"1996","unstructured":"Birge SJ (1996) Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 44(7):865\u2013870. https:\/\/doi.org\/10.1111\/j.1532-5415.1996.tb03749.x","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"11417_CR77","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1136\/gutjnl-2024-331880","volume":"73","author":"ZH Li","year":"2024","unstructured":"Li ZH, Weng J, Yan J et al (2024) Puerarin alleviates atherosclerosis via the inhibition of Prevotella copri and its trimethylamine production. Gut 73(12):1934\u20131943. https:\/\/doi.org\/10.1136\/gutjnl-2024-331880","journal-title":"Gut"},{"issue":"3","key":"11417_CR78","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuroscience.2005.06.017","volume":"138","author":"VW Henderson","year":"2006","unstructured":"Henderson VW (2006) Estrogen-containing hormone therapy and Alzheimer\u2019s disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 138(3):1031\u20131039. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.06.017","journal-title":"Neuroscience"},{"issue":"12","key":"11417_CR79","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1042\/CS20070443","volume":"115","author":"CM Webb","year":"2008","unstructured":"Webb CM, Hayward CS, Mason MJ et al (2008) Coronary vasomotor and blood flow responses to isoflavone-intact soya protein in subjects with coronary heart disease or risk factors for coronary heart disease. Clin Sci 115(12):353\u2013359. https:\/\/doi.org\/10.1042\/CS20070443","journal-title":"Clin Sci"},{"key":"11417_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111253","volume":"137","author":"MS Tahir","year":"2021","unstructured":"Tahir MS, Almezgagi M, Zhang Y et al (2021) Mechanistic new insights of flavonols on neurodegenerative diseases. Biomed Pharmacother 137:111253. https:\/\/doi.org\/10.1016\/j.biopha.2021.111253","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"11417_CR81","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.3390\/nu11112649","volume":"11","author":"LR Chen","year":"2019","unstructured":"Chen LR, Ko NY, Chen KH (2019) Isoflavone supplements for menopausal women: a systematic review. Nutrients 11(11):2649. https:\/\/doi.org\/10.3390\/nu11112649","journal-title":"Nutrients"},{"issue":"4","key":"11417_CR82","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2478\/v10102-009-0021-3","volume":"2","author":"E Miadokov\u00e1","year":"2009","unstructured":"Miadokov\u00e1 E (2009) Isoflavonoids-an overview of their biological activities and potential health benefits. Interdiscip Toxicol 2(4):211\u2013218. https:\/\/doi.org\/10.2478\/v10102-009-0021-3","journal-title":"Interdiscip Toxicol"},{"key":"11417_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104602","volume":"107","author":"Z Sang","year":"2021","unstructured":"Sang Z, Shi J, Zhou Y et al (2021) Development of genistein-O-alkylamines derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Chem 107:104602. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104602","journal-title":"Bioorg Chem"},{"issue":"9","key":"11417_CR84","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1007\/s12035-016-0215-6","volume":"54","author":"KP Devi","year":"2017","unstructured":"Devi KP, Shanmuganathan B, Manayi A et al (2017) Molecular and therapeutic targets of genistein in Alzheimer\u2019s disease. Mol Neurobiol 54(9):7028\u20137041. https:\/\/doi.org\/10.1007\/s12035-016-0215-6","journal-title":"Mol Neurobiol"},{"issue":"6","key":"11417_CR85","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/j.1471-4159.2006.04434.x","volume":"101","author":"H Schroeter","year":"2007","unstructured":"Schroeter H, Bahia P, Spencer JP et al (2007) (-)-Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. J Neurochem 101(6):1596\u20131606. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04434.x","journal-title":"J Neurochem"},{"issue":"4","key":"11417_CR86","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/j.1471-4159.2007.04841.x","volume":"103","author":"D Vauzour","year":"2007","unstructured":"Vauzour D, Vafeiadou K, Rice-Evans C et al (2007) Activation of pro-survival Akt and ERK1\/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J Neurochem 103(4):1355\u20131367. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04841.x","journal-title":"J Neurochem"},{"issue":"44","key":"11417_CR87","doi-asserted-by":"publisher","first-page":"16568","DOI":"10.1073\/pnas.0607822103","volume":"103","author":"P Maher","year":"2006","unstructured":"Maher P, Akaishi T, Abe K (2006) Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc Natl Acad Sci USA 103(44):16568\u201316573. https:\/\/doi.org\/10.1073\/pnas.0607822103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"37","key":"11417_CR88","doi-asserted-by":"publisher","first-page":"34783","DOI":"10.1074\/jbc.M305063200","volume":"278","author":"JPE Spencer","year":"2003","unstructured":"Spencer JPE, Rice-Evans C, Williams RJ (2003) Modulation of pro-survival Akt\/protein kinase B and ERK1\/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 278(37):34783\u201334793. https:\/\/doi.org\/10.1074\/jbc.M305063200","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"11417_CR89","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1042\/0264-6021:3580547","volume":"358","author":"H Schroeter","year":"2001","unstructured":"Schroeter H, Spencer JP, Rice-Evans C et al (2001) Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 358(Pt 3):547\u2013557. https:\/\/doi.org\/10.1042\/0264-6021:3580547","journal-title":"Biochem J"},{"issue":"2","key":"11417_CR90","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1017\/S0029665110000054","volume":"69","author":"JPE Spencer","year":"2010","unstructured":"Spencer JPE (2010) Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain. Proc Nutr Soc 69(2):244\u2013260. https:\/\/doi.org\/10.1017\/S0029665110000054","journal-title":"Proc Nutr Soc"},{"issue":"4","key":"11417_CR91","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1023\/a:1007614613771","volume":"16","author":"D Commenges","year":"2000","unstructured":"Commenges D, Scotet V, Renaud S et al (2000) Intake of flavonoids and risk of dementia. Eur J Epidemiol 16(4):357\u2013363. https:\/\/doi.org\/10.1023\/a:1007614613771","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"11417_CR92","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/aje\/kwm036","volume":"165","author":"L Letenneur","year":"2007","unstructured":"Letenneur L, Proust-Lima C, Le Gouge A et al (2007) Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 165(12):1364\u20131371. https:\/\/doi.org\/10.1093\/aje\/kwm036","journal-title":"Am J Epidemiol"},{"issue":"s1","key":"11417_CR93","doi-asserted-by":"publisher","first-page":"S275","DOI":"10.3233\/JAD-240308","volume":"101","author":"J Vi\u00f1a","year":"2024","unstructured":"Vi\u00f1a J, Borr\u00e1s C, Mas-Bargues C (2024) Genistein, a phytoestrogen, delays the transition to dementia in prodromal Alzheimer\u2019s disease patients. J Alzheimers Dis 101(s1):S275\u2013S283. https:\/\/doi.org\/10.3233\/JAD-240308","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"11417_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01097-2","volume":"14","author":"J Vi\u00f1a","year":"2022","unstructured":"Vi\u00f1a J, Escudero J, Baquero M et al (2022) Genistein effect on cognition in prodromal Alzheimer\u2019s disease patients. The GENIAL clinical trial. Alzheimers Res Ther 14(1):164. https:\/\/doi.org\/10.1186\/s13195-022-01097-2","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"11417_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2100","volume":"11","author":"X Duan","year":"2021","unstructured":"Duan X, Li Y, Xu F et al (2021) Study on the neuroprotective effects of Genistein on Alzheimer\u2019s disease. Brain Behav 11(5):e02100. https:\/\/doi.org\/10.1002\/brb3.2100","journal-title":"Brain Behav"},{"issue":"9","key":"11417_CR96","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/j.bmcl.2013.02.095","volume":"23","author":"RS Li","year":"2013","unstructured":"Li RS, Wang XB, Hu XJ et al (2013) Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer\u2019s disease. Bioorg Med Chem Lett 23(9):2636\u20132641. https:\/\/doi.org\/10.1016\/j.bmcl.2013.02.095","journal-title":"Bioorg Med Chem Lett"},{"key":"11417_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/8587260","volume":"2017","author":"I Cruz","year":"2017","unstructured":"Cruz I, Puthongking P, Cravo S et al (2017) Xanthone and flavone derivatives as dual agents with acetylcholinesterase inhibition and antioxidant activity as potential anti-Alzheimer agents. J Chem 2017:1\u201316. https:\/\/doi.org\/10.1155\/2017\/8587260","journal-title":"J Chem"},{"issue":"4","key":"11417_CR98","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bmc.2015.01.005","volume":"23","author":"Z Sang","year":"2015","unstructured":"Sang Z, Li Y, Qiang X et al (2015) Multifunctional scutellarin-rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem 23(4):668\u2013680. https:\/\/doi.org\/10.1016\/j.bmc.2015.01.005","journal-title":"Bioorg Med Chem"},{"key":"11417_CR99","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ejmech.2015.02.063","volume":"94","author":"Z Sang","year":"2015","unstructured":"Sang Z, Qiang X, Li Y et al (2015) Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 94:348\u2013366. https:\/\/doi.org\/10.1016\/j.ejmech.2015.02.063","journal-title":"Eur J Med Chem"},{"key":"11417_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112180","volume":"192","author":"Z Sang","year":"2020","unstructured":"Sang Z, Wang K, Shi J et al (2020) The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 192:112180. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112180","journal-title":"Eur J Med Chem"},{"key":"11417_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111958","volume":"187","author":"Z Sang","year":"2020","unstructured":"Sang Z, Wang K, Shi J et al (2020) Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 187:111958. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111958","journal-title":"Eur J Med Chem"},{"key":"11417_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114216","volume":"233","author":"A Yang","year":"2022","unstructured":"Yang A, Liu C, Zhang H et al (2022) A multifunctional anti-AD approach: design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives. Eur J Med Chem 233:114216. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114216","journal-title":"Eur J Med Chem"},{"key":"11417_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105976","volume":"166","author":"C Liu","year":"2021","unstructured":"Liu C, Kou X, Wang X et al (2021) Novel chrysin derivatives as hidden multifunctional agents for anti-Alzheimer\u2019s disease: design, synthesis and in vitro evaluation. Eur J Pharm Sci 166:105976. https:\/\/doi.org\/10.1016\/j.ejps.2021.105976","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"11417_CR104","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11030-024-10913-w","volume":"29","author":"A Yang","year":"2025","unstructured":"Yang A, Yi X, Zhang H et al (2025) Study of multifunctional anti-AD ligands: design, synthesis, X-ray crystal structure and biological evaluation of diosmetin derivatives. Mol Divers 29(2):1323\u20131335. https:\/\/doi.org\/10.1007\/s11030-024-10913-w","journal-title":"Mol Divers"},{"key":"11417_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.128316","volume":"49","author":"J Wu","year":"2021","unstructured":"Wu J, Kou X, Ju H et al (2021) Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem Lett 49:128316. https:\/\/doi.org\/10.1016\/j.bmcl.2021.128316","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"11417_CR106","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1080\/14756366.2022.2041627","volume":"37","author":"J Yang","year":"2022","unstructured":"Yang J, Zhou Y, Ban Y et al (2022) Development of naringenin-O-alkylamine derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease. J Enzyme Inhib Med Chem 37(1):792\u2013816. https:\/\/doi.org\/10.1080\/14756366.2022.2041627","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11417_CR107","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ejmech.2014.02.045","volume":"76","author":"X Qiang","year":"2014","unstructured":"Qiang X, Sang Z, Yuan W et al (2014) Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 76:314\u2013331. https:\/\/doi.org\/10.1016\/j.ejmech.2014.02.045","journal-title":"Eur J Med Chem"},{"issue":"1","key":"11417_CR108","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.apsb.2014.12.008","volume":"5","author":"X Zhang","year":"2015","unstructured":"Zhang X, Wang J, Hong C et al (2015) Design, synthesis and evaluation of genistein-polyamine conjugates as multi-functional anti-Alzheimer agents. Acta Pharm Sin B 5(1):67\u201373. https:\/\/doi.org\/10.1016\/j.apsb.2014.12.008","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"11417_CR109","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/cbdd.13414","volume":"93","author":"C Hong","year":"2019","unstructured":"Hong C, Guo HY, Chen S et al (2019) Synthesis and biological evaluation of genistein-O-alkylamine derivatives as potential multifunctional anti-Alzheimer agents. Chem Biol Drug Des 93(2):188\u2013200. https:\/\/doi.org\/10.1111\/cbdd.13414","journal-title":"Chem Biol Drug Des"},{"key":"11417_CR110","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1039\/C6RA26134E","volume":"7","author":"C Li","year":"2017","unstructured":"Li C, Sun P, Yu H et al (2017) Scavenging ability of dendritic PAMAM bridged hindered phenolic antioxidants towards DPPH\u02d9 and ROO\u02d9 free radicals. RSC Adv 7:1869\u20131876. https:\/\/doi.org\/10.1039\/C6RA26134E","journal-title":"RSC Adv"},{"key":"11417_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.130459","volume":"1239","author":"X Kou","year":"2021","unstructured":"Kou X, Liu J, Chen Y et al (2021) Emodin derivatives with multi-factor anti-AD activities: AChE inhibitor, anti-oxidant and metal chelator. J Mol Struct 1239:130459. https:\/\/doi.org\/10.1016\/j.molstruc.2021.130459","journal-title":"J Mol Struct"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11417-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11417-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11417-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:39:18Z","timestamp":1783161558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11417-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":111,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["11417"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11417-x","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missed Article note is included.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}